151 related articles for article (PubMed ID: 3436332)
1. Effects of quinidine on ventricular repolarization.
Brugada J; Sassine A; Escande D; Masse C; Puech P
Eur Heart J; 1987 Dec; 8(12):1340-5. PubMed ID: 3436332
[TBL] [Abstract][Full Text] [Related]
2. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
3. Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig.
Osadchii OE
Can J Physiol Pharmacol; 2013 Apr; 91(4):306-15. PubMed ID: 23627842
[TBL] [Abstract][Full Text] [Related]
4. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
Franz MR; Costard A
Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
[TBL] [Abstract][Full Text] [Related]
5. Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: II. In vivo study.
Anyukhovsky EP; Sosunov EA; Feinmark SJ; Rosen MR
Circulation; 1997 Dec; 96(11):4019-26. PubMed ID: 9403627
[TBL] [Abstract][Full Text] [Related]
6. Effects of halothane and quinidine on intracardiac conduction and QTc interval in pentobarbital-anesthetized dogs.
Gallagher JD
Anesth Analg; 1992 Nov; 75(5):688-95. PubMed ID: 1416119
[TBL] [Abstract][Full Text] [Related]
7. Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I. In vitro study.
Sosunov EA; Anyukhovsky EP; Rosen MR
Circulation; 1997 Dec; 96(11):4011-8. PubMed ID: 9403626
[TBL] [Abstract][Full Text] [Related]
8. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration.
Stroobandt R; Brachmann J; Kesteloot H; Kübler W; Senges J
Eur Heart J; 1986 Jan; 7(1):47-53. PubMed ID: 3956522
[TBL] [Abstract][Full Text] [Related]
9. [Effects of quinidine on pinacidil-induced transmural dispersion of repolarization in canine right ventricular wall].
Luo J; Yang XC; Wang LF; Zhou P; Li CL; Wang MS; Gao Y; Wang LZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):369-71. PubMed ID: 15932676
[TBL] [Abstract][Full Text] [Related]
10. Interactions of ethanol and quinidine on contractility and myocyte action potential in the rat ventricle.
Guthrie SK; Wilde DW; Brown RA; Savage AO; Bleske B
J Electrocardiol; 1995 Jan; 28(1):39-47. PubMed ID: 7897336
[TBL] [Abstract][Full Text] [Related]
11. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
12. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
13. The effect of quinidine and mexiletine on the adaptation of ventricular refractoriness to an increase in rate.
Rosenheck S; Schmaltz S; Kadish AH; Summitt J; Morady F
Am Heart J; 1991 Feb; 121(2 Pt 1):512-7. PubMed ID: 1990756
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
Milberg P; Frommeyer G; Uphaus T; Kaiser D; Osada N; Breithardt G; Eckardt L
J Cardiovasc Pharmacol; 2012 Jan; 59(1):92-100. PubMed ID: 21964157
[TBL] [Abstract][Full Text] [Related]
15. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
Osadchii OE
Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
17. Epicardial activation patterns of torsade de pointes in canine hearts with quinidine-induced long QT interval but without myocardial infarction.
Inoue H; Murakawa Y; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
Am Heart J; 1986 Jun; 111(6):1080-7. PubMed ID: 3716981
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
Duker G; Almgren O; Carlsson L
J Cardiovasc Pharmacol; 1992 Sep; 20(3):458-65. PubMed ID: 1279293
[TBL] [Abstract][Full Text] [Related]
19. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
20. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
